May Han
Private Equity Investor at Cure Ventures Management LP
Profile
May Han is currently a Partner at Cure Ventures Management LP since 2021.
Prior to this, she worked as a Director at Novartis AG from 2013 to 2021 and as a Director at AVEO Pharmaceuticals, Inc. from 2003 to 2012.
Dr. Han received her undergraduate degree from Peking University in 1990 and her doctorate degree from Yale University in 1996.
May Han active positions
Companies | Position | Start |
---|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 2021-08-31 |
Former positions of May Han
Companies | Position | End |
---|---|---|
NOVARTIS AG | Director/Board Member | 2021-09-29 |
AVEO PHARMACEUTICALS, INC. | Director/Board Member | 2012-06-29 |
Training of May Han
Peking University | Undergraduate Degree |
Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NOVARTIS AG | Health Technology |
Private companies | 2 |
---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- May Han